# Ezetimibe (+) Simvastatin vs. Atorvastatin Comparative Study in DM or Metabolic Syndrome Patients (0653A-093)

> **NCT00157924** · PHASE4 · COMPLETED · sponsor: **Organon and Co** · enrollment: 190 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** simvastatin (+) ezetimibe
- **DRUG:** atorvastatin

## Key facts

- **NCT ID:** NCT00157924
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 190 (ACTUAL)
- **Last updated:** 2024-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00157924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00157924, "Ezetimibe (+) Simvastatin vs. Atorvastatin Comparative Study in DM or Metabolic Syndrome Patients (0653A-093)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00157924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*